We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+23.44%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$90.5B
AUM Growth
+$5.41B
(+6.4%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
5,141
New
939
Increased
1,573
Reduced
1,769
Closed
818
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$732M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$553M |
| 3 |
Applied Materials
AMAT
|
+$327M |
| 4 |
Intuit
INTU
|
+$320M |
| 5 |
Chevron
CVX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$298M |
| 5 |
Qualcomm
QCOM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 5.76% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
Inovio Pharmaceuticals
INO
$148M
| $40K | ﹤0.01% |
36,391
+11,554
| +47% | +$13.7K |
|
4252
Microbot Medical
MBOT
$96.7M
| $39.6K | ﹤0.01% |
20,286
-105,307
| -84% | -$215K |
|
4253
Eve Holding
EVEX
$774M
| $39.3K | ﹤0.01% |
15,659
-2,071
| -12% | -$5.97K |
|
4254
DocGo
DCGO
$39.8M
| $38.1K | ﹤0.01% |
73,781
-103,516
| -58% | -$61.9K |
|
4255
Biote Corp
BTMD
$44.2M
| $37.3K | ﹤0.01% |
+19,736
| New | +$40.7K |
|
4256
Werewolf Therapeutics
HOWL
$47M
| $37.2K | ﹤0.01% |
+103,242
| New | +$62.9K |
|
4257
VinFast Auto
VFS
$7.21B
| $36.9K | ﹤0.01% |
+11,824
| New | +$44.4K |
|
4258
Clear Channel Outdoor Holdings
CCO
$1.21B
| $35.3K | ﹤0.01% |
14,575
-107,983
| -88% | -$259K |
|
4259
Wrap Technologies
WRAP
$103M
| $35.1K | ﹤0.01% |
+27,173
| New | +$38.3K |
|
4260
Tempest Therapeutics
TPST
$17M
| $34.3K | ﹤0.01% |
+30,900
| New | +$51K |
|
4261
Investcorp Credit Management BDC
ICMB
$12.8M
| $34.3K | ﹤0.01% |
+29,277
| New | +$43.6K |
|
4262
Drilling Tools International
DTI
$93.9M
| $33.9K | ﹤0.01% |
+17,577
| New | +$52.4K |
|
|
TONX
4263
TON Strategy Co
TONX
$183M
| $33K | ﹤0.01% |
12,950
+256
| +2% | +$757 |
|
|
CNTN
4264
Canton Strategic Holdings
CNTN
$182M
| $33K | ﹤0.01% |
+11,685
| New | +$36.9K |
|
4265
Rani Therapeutics
RANI
$99.9M
| $31.9K | ﹤0.01% |
41,902
+25,501
| +155% | +$22.6K |
|
4266
Playboy Inc
PLBY
$140M
| $31.7K | ﹤0.01% |
26,019
-218,276
| -89% | -$331K |
|
4267
Hyperfine
HYPR
$86.2M
| $31.6K | ﹤0.01% |
23,375
-31,185
| -57% | -$45K |
|
4268
Children's Place
PLCE
$62.5M
| $30.7K | ﹤0.01% |
10,064
-5,947
| -37% | -$20.2K |
|
4269
HF Foods Group
HFFG
$98.4M
| $29.9K | ﹤0.01% |
+21,178
| New | +$41K |
|
4270
Context Therapeutics
CNTX
$33.2M
| $29.2K | ﹤0.01% |
+52,709
| New | +$107K |
|
4271
CBAK Energy Technology Ltd
CBAT
$87.2M
| $28.7K | ﹤0.01% |
48,453
-72,288
| -60% | -$55.3K |
|
4272
Sportsman's Warehouse
SPWH
$50.9M
| $28.5K | ﹤0.01% |
+21,406
| New | +$29.3K |
|
4273
Lexicon Pharmaceuticals
LXRX
$997M
| $28.2K | ﹤0.01% |
+11,741
| New | +$22.9K |
|
4274
INmune Bio
INMB
$67.7M
| $26.1K | ﹤0.01% |
16,043
+13
| +0.1% | +$18 |
|
4275
Inhibikase Therapeutics
IKT
$349M
| $26.1K | ﹤0.01% |
12,854
-18,135
| -59% | -$32.5K |
|
Similar funds
VM
Squarepoint's Q2 2026 Portfolio in Review
As of Q2 2026, Squarepoint held 5,141 positions worth $90.5B, up 6.4% from $85.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint's Q2 2026 filing shows 939 new, 1,573 increased, 1,769 reduced and 818 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q2 2026 buy was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $732M increase.
- Squarepoint's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.03B.
- Squarepoint fully exited VanEck Semiconductor ETF in Q2 2026, selling an estimated $192M.
- Squarepoint's ten largest holdings make up 20% of its $90.5B portfolio in Q2 2026.
- Squarepoint opened 939 new positions and closed 818 in Q2 2026.
- Squarepoint's portfolio value rose 6.4% quarter-over-quarter to $90.5B.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.